Canada's Perimeter Medical Imaging AI Q2 loss narrows on lower expenses

Perimeter Medical Imaging AI

20/08/2026 21:42

Overview
Canada medical imaging firm's preliminary Q2 revenue was flat sequentially, up 31% from Q1
Preliminary Q2 net loss narrowed to $2.6 mln, or $0.02 per share

Outlook
Company did not provide specific financial guidance for upcoming quarters or the full year in press release

Result Drivers
LEGACY PRODUCT REVENUE - Co said recurring revenue from S-Series OCT grew 31% sequentially in Q2, driven by consumables, leases, maintenance, and warranty sales
LOWER OPERATING EXPENSES - Q2 operating expenses fell 28% from prior year, contributing to narrower net loss

Company press release: ID:nPn9Y14j6a

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Loss Per Share
 
$0.02
 
Q2 Net Loss
 
$2.60 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Perimeter Medical Imaging AI Inc is C$1.37, about 270.3% above its August 19 closing price of C$0.37

Reuters Recommended Reads
Aug 18 - Iridex Q2 revenue falls as retina sales decline
Aug 19 - Accuray Q4 revenue falls as tariff concerns, geopolitical tensions weigh on demand
Aug 18 - GE HealthCare appoints William Grogan as CFO, replacing Jay Saccaro

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)